SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-08-011534
Filing Date
2008-06-05
Accepted
2008-06-05 21:12:37
Documents
2
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3809
2 ex24kirkman.txt EX-24 1982
  Complete submission text file 0001179110-08-011534.txt   7754
Mailing Address C/O XCYTE THERAPIES, INC. 1124 COLUMBIA STREET, SUITE 130 SEATTLE WA 98104
Business Address 206.262.6200
KIRKMAN ROBERT L (Reporting) CIK: 0001242122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 08884230

Mailing Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004
Business Address 110 - 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004 425-450-0370
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9